STOCK TITAN

Newtopia and Eastern Health Improve Outcomes for Individuals Living with Type 2 Diabetes

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

Newtopia Inc. (NEWUF) announced at the 2022 Diabetes Canada and CSEM Conference the successful outcomes of a trial conducted with Eastern Health aimed at combating diabetes in Newfoundland and Labrador. Approximately 175,000 residents face diabetes risks, and the trial showed that participants experienced an average weight loss of 6.4% over 10 months. Furthermore, A1c levels decreased by 1.1 for participants with high initial levels. With an impressive engagement rate of 81%, Newtopia's approach is proving effective in improving health outcomes through personalized coaching.

Positive
  • Participants achieved an average weight loss of 6.4% at 10 months.
  • A1c levels declined by an average of 1.1 for those starting at 9.0 or above.
  • 81% participant engagement rate indicates strong program effectiveness.
Negative
  • None.

Abstract presented by Eastern Health at the 2022 Diabetes Canada and Canadian Society of Endocrinology and Metabolism (CSEM) Professional Conference in Calgary.  

TORONTO, Nov. 14, 2022 /PRNewswire/ - Newtopia Inc. ("Newtopia" or the "Company") (TSXV: NEWU) (OTCQB: NEWUF), a tech-enabled whole health platform creating sustainable habits that prevent, slow and reverse chronic disease, today announced the presentation of the evaluation of outcomes at Canada's most highly anticipated diabetes-related conference.  The results are from a joint, value-based innovation trial with Eastern Health being tested with the goal to reduce the significant diabetes burden in Newfoundland and Labrador. 

The trial itself evolved out of Eastern Health's recognition of the need to improve health outcomes for approximately 30% of the population - nearly 175,000 Newfoundland and Labrador residents - who live with, or are at risk of, developing diabetes.  Using Newtopia's personalized lifestyle and habit change platform, participants in the trial in Newfoundland and Labrador received 1:1 dedicated health coaching delivered virtually.  

Weight loss trends among participants showed a decrease from baseline of 3.5% of body weight at 6 months and 6.4% at 10 months.  What's more, among participants with two or more A1c test results, A1c declined by an average of 0.5, and 1.1 for those with an initial A1c of 9.0 or above.  While the trial results are impressive, the engagement levels of 81% among participants, whose average age is 60-years-old, further highlights the successful outcomes that flow from Newtopia's humans-helping-humans approach amplified by technology.   

"These results are especially encouraging given the number of people in Newfoundland and Labrador who have diabetes," said Judy O'Keefe, Vice President of Clinical Services, Eastern Health.  "Eastern Health is always interested in innovative products and solutions that have the potential of improving the health of our patients, clients and residents. This trial has shown the success we can have when patients are directly involved in their own care and from the comfort of their own home. It is also an example of the success of providing primary health care that is preventative and patient-centered." 

"As a Canadian-founded health tech leader, we value our collaboration with Eastern Health and are delighted to see Canadians benefiting from our habit change innovation to prevent, reverse and slow chronic disease," said Jeff Ruby, Founder and CEO of Newtopia. "In addition to the compelling engagement and clinical outcomes, we are pleased to see Eastern Health lead innovation in both slowing and reversing type-2 diabetes and value-based contracting.  We look forward to continuing our relationship with Eastern Health, thereby delivering better diabetes health outcomes to even more of the people of Newfoundland and Labrador, and in time across Canada."   

These pilot results are also consistent with Newtopia's recent receipt of the highest Full-Plus recognition from the Centers for Disease Control and Prevention for delivering a proven, highly effective alternative diabetes prevention program.

About Newtopia

Newtopia is a personalized whole health platform helping people create positive lifelong habits that prevent, slow, or reverse chronic disease while reducing healthcare costs. The platform leverages genetic, social and behavioral insights to create individualized prevention programs with a focus on metabolic disease, diabetes, mental health challenges, hypertension, weight management and musculoskeletal disorders. With a person-centered approach that combines virtual care, digital tools, connected devices and actionable data science, Newtopia delivers sustainable clinical and financial outcomes. Newtopia serves some of the largest nationwide employers and health plans and is currently listed in Canada on the Toronto Stock Exchange (TSXV: NEWU) and is quoted in the US on the OTCQB® Venture Market (OTCQB: NEWUF). To learn more, visit newtopia.comLinkedIn or Twitter.

About Eastern Health  

Eastern Health is the largest, integrated health authority in Newfoundland and Labrador employing approximately 13,000 dedicated employees, over 700 medical staff, and is supported by hundreds of volunteers, including members of numerous auxiliaries and fundraising foundations. With an annual budget of approximately $1.7 billion, the authority offers the full continuum of health and community services including public health, long-term care, community services, hospital care and unique provincial programs and services. Serving a population of over 300,000, Eastern Health's geographic boundaries extend west from St. John's to Port Blandford including all communities on the Avalon, Burin and Bonavista Peninsulas.

Forward Looking Statements

This news release contains forward-looking information and forward-looking statements, within the meaning of applicable Canadian securities legislation, and forward looking statements, within the meaning of applicable United States securities legislation (collectively, "forward-looking statements"), which reflects management's expectations regarding Newtopia's future growth, results from operations (including, without limitation, future production and capital expenditures), performance (both operational and financial) and business prospects and opportunities. Wherever possible, words such as "predicts", "projects", "targets", "plans", "expects", "does not expect", "budget", "scheduled", "estimates", "forecasts", "anticipate" or "does not anticipate", "believe", "intend" and similar expressions or statements that certain actions, events or results "may", "could", "would", "might" or "will" be taken, occur or be achieved, or the negative or grammatical variation thereof or other variations thereof, or comparable terminology have been used to identify forward-looking statements. All statements other than statements of historical fact may be forward-looking information. Such statements reflect Newtopia's current views and intentions with respect to future events, based on information available to Newtopia, and are subject to certain risks, uncertainties, and assumptions. Material factors or assumptions were applied in providing forward-looking information. While forward-looking statements are based on data, assumptions and analyses that Newtopia believes are reasonable under the circumstances, whether actual results, performance or developments will meet Newtopia's expectations and predictions depends on a number of risks and uncertainties that could cause the actual results, performance and financial condition of Newtopia to differ materially from its expectations. Forward-looking statements are not a guarantee and are based on a number of estimates and assumptions management believes to be relevant and reasonable, whether actual results, performance or developments will meet Newtopia's expectations and predictions depends on a number of risks and uncertainties that could cause the actual results, performance and financial condition of Newtopia to differ materially from its expectations. Certain of the "risk factors" that could cause actual results to differ materially from Newtopia's forward-looking statements in this press release include, without limitation: the termination of contracts by clients, risks related to COVID-19 including various recommendations, orders and measures of governmental authorities to try to limit the pandemic, including travel restrictions, border closures, non-essential business closures, quarantines, self-isolations, shelters- in-place and social distancing, disruptions to markets, economic activity, financing, supply chains and sales channels, and a deterioration of general economic conditions including a possible national or global recession; and other general economic, market and business conditions and factors, including the risk factors discussed or referred to in Newtopia's disclosure documents, filed with the securities regulatory authorities in certain provinces of Canada and available at www.sedar.com including Newtopia's final long form prospectus dated March 30, 2020.

Should any factor affect Newtopia's in an unexpected manner, or should assumptions underlying the forward- looking information prove incorrect, the actual results or events may differ materially from the results or events predicted. Any such forward-looking information is expressly qualified in its entirety by this cautionary statement. Moreover, Newtopia does not assume responsibility for the accuracy or completeness of such forward-looking information. The forward-looking information included in this press release is made as of the date of this press release, and Newtopia undertakes no obligation to publicly update or revise any forward-looking information, other than as required by applicable law.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/newtopia-and-eastern-health-improve-outcomes-for-individuals-living-with-type-2-diabetes-301675898.html

SOURCE Newtopia Inc.

FAQ

What were the results of Newtopia's trial with Eastern Health on diabetes outcomes?

Newtopia's trial results showed an average weight loss of 6.4% over 10 months and a 1.1 decline in A1c levels for participants with an initial A1c of 9.0 or higher.

How many residents in Newfoundland and Labrador are at risk for diabetes?

Approximately 175,000 residents in Newfoundland and Labrador are living with, or are at risk of developing diabetes.

What is Newtopia's stock symbol?

Newtopia is listed under the stock symbol NEWUF on the OTCQB Venture Market.

What is Newtopia's engagement rate among trial participants?

The engagement rate among participants in the trial was 81%.

Where was the trial evaluation presented?

The trial evaluation was presented at the 2022 Diabetes Canada and CSEM Conference in Calgary.

NEWTOPIA INC

OTC:NEWUF

NEWUF Rankings

NEWUF Latest News

NEWUF Stock Data

2.84M
134.05M
13.05%
0.8%
Health Information Services
Healthcare
Link
United States of America
Toronto